Myriad Myriad Genetics Q3 Revenues Increase 15 Percent The company reported $167.3 million in revenues compared to $145.2 million last year, beating the consensus Wall Street estimate. People in the News: New Appointments at Myriad Genetics, Becton Dickinson, Delfi Diagnostics, More Illumina, Merck Partner to Advance Homologous Recombination Deficiency CDx, Research Assay Under the terms of the deal, Illumina will develop a new HRD CDx for the EU and UK markets and a research-use only HRD assay that will be add-on content for its TSO 500 panel. GenomeWeb Index up Slightly in August as Guardant Health Leads on Strength of Q2 Earnings The GenomeWeb Index outperformed the Dow Jones last month, but underperformed the Nasdaq and the Nasdaq Biotechnology Index. Noviscend Inks Canadian Distribution Deal for Myriad Genetics Tests The deal covers a range of Myriad's tests including risk assessment tests for breast, prostate, and other cancers. Aug 6, 2021 New Products Posted to GenomeWeb: HTG Molecular, Myriad Genetics, Eclipse Bioinnovations, More Aug 3, 2021 Myriad Genetics More Than Doubles Quarterly Revenues Jun 5, 2021 Myriad Genetics Recalibrates Breast Cancer PRS for All Ancestries in Anticipation of Broader Launch Premium May 24, 2021 Myriad Genetics Sells Pharma Research Services Business to Q2 Solutions May 5, 2021 Myriad Genetics Projects Return to Profitability by Year End, Details Long-Term Growth Plan Premium May 3, 2021 Myriad Genetics' Quarterly Revenues Increase 6 Percent May 3, 2021 Labcorp to Acquire Myriad Genetics' Vectra Rheumatoid Arthritis Test for $150M Apr 27, 2021 Castle Biosciences Acquires Myriad Genetics' MyPath Melanoma Test, Lab for $32.5M Mar 24, 2021 Intermountain Gets National Stage, Myriad Adds Tumor Profiling Panel With Combined Test Offering Premium Mar 2, 2021 Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service Feb 23, 2021 Myriad Genetics Quarterly Revenues Decline 21 Percent Feb 19, 2021 People in the News: Peer Schatz Board Appointments at Siemens, Centogene; More Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Jan 5, 2021 Myriad Genetics to Sell Vectra DA Business, Reorganize International Presence Jan 5, 2021 GenomeWeb Index Gains 49 Percent in 2020, Outperforming Wider Markets Dec 9, 2020 Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project Dec 1, 2020 Veracyte, Twist Bioscience Lead November GenomeWeb Index on Strong Earnings Growth Nov 16, 2020 Myriad Genetics Expands MyChoice CDx Access Through Partnerships in Europe, China Nov 16, 2020 Myriad Genetics Bets Fetal DNA Enrichment Method Will Further Increase Uptake of NIPS Test Premium Load More Breaking News Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease Danaher Prices $1B Offering of Senior Notes Discovery Life Sciences Acquires Contract Research Firm In Vitro ADMET Laboratories Audere Gets FDA Emergency Use Authorization for SARS-CoV-2 At-Home Sample Collection Kit GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy The Scan Science Confidence Boost The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic. Appeal and Funds Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports. Surveillance for Variants Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance. Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome In Nature this week: plant genome sequencing dominated by affluent countries, and more.